- Trials with a EudraCT protocol (21)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
21 result(s) found for: Antibiotic associated diarrhea.
Displaying page 1 of 2.
EudraCT Number: 2012-001542-18 | Sponsor Protocol Number: AAD-EU2012 | Start Date*: 2012-07-12 | |||||||||||
Sponsor Name:DuPont Nutrition and Health Active Nutrition | |||||||||||||
Full Title: Effect of a probiotic formula on reducing the risk for antibiotic-associated diarrhea | |||||||||||||
Medical condition: Antibiotic-associated diarrhea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004629-42 | Sponsor Protocol Number: ENTER_L_01125 | Start Date*: 2015-04-03 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Bacillus Clausii in Preventing Antibiotic-Associated Diarrhea Among Filipino Infant and Children: A Multi-Center, Randomized, Open-Label Controlled (Treatment vs No Treatment) Clinical Trial of Eff... | |||||||||||||
Medical condition: Diarrhea associated to antibiotics | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000970-10 | Sponsor Protocol Number: LPS16140 | Start Date*: 2020-09-09 | |||||||||||
Sponsor Name:Sanofi Aventis Groupe | |||||||||||||
Full Title: Phase III, randomized, double blind, parallel groups, clinical trial to evaluate the efficacy and safety of Bacillus clausii versus placebo in the prevention of antibiotic associated diarrhea (AAD)... | |||||||||||||
Medical condition: Antibiotic associated diarrhea (AAD) in children | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017374-20 | Sponsor Protocol Number: BNI-2009-01 | Start Date*: 2010-04-19 | |||||||||||||||||||||
Sponsor Name:Bernhard-Nocht-Institute for Tropical Medicine | |||||||||||||||||||||||
Full Title: Probiotic Saccharomyces boulardii for the prevention of antibiotic-associated diarrhoea – randomised, double-blind, placebo-controlled trial | |||||||||||||||||||||||
Medical condition: Antibiotic - associated - Diarrhoea (AAD) Clostridium difficile - associated - Diarrhoea (CDAD) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000500-16 | Sponsor Protocol Number: MU0524 | Start Date*: 2006-09-13 | |||||||||||
Sponsor Name:Ardeypharm GmbH | |||||||||||||
Full Title: E. coli Stamm Nissle 1917 zur Behandlung des postinfektiösen/Antibiotika-assoziierten Reizdarmsyndroms mit Diarrhö E. coli strain Nissle 1917 for the treatment of post-infectious/antibiotic-associ... | |||||||||||||
Medical condition: postinfectious/antibiotic-associated Irritable Bowel Syndrome with diarrhea | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010713-69 | Sponsor Protocol Number: LINPT01 | Start Date*: 2009-05-13 |
Sponsor Name:Lek Pharmaceuticals d.d. | ||
Full Title: Randomized, placebo controlled, double-blind, parallel group, multicentric Phase IV study on the clinical efficacy of lactic acid bacteria in form of hard capsules (capsule contains not less than 2... | ||
Medical condition: Antibiotic associated diarrhea | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006269-17 | Sponsor Protocol Number: SPON1069-11 | Start Date*: 2012-11-16 | |||||||||||
Sponsor Name:Cardiff University, Research & Development Commercial Department | |||||||||||||
Full Title: A double blind placebo controlled randomised clinical trial to study the effect of Probiotics for the prevetion or amelioration of Antibiotic Associated Diarrhoea in residents of care homes in Sout... | |||||||||||||
Medical condition: Antibiotic Associated Diarrhoea | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002346-32 | Sponsor Protocol Number: SB-2-004-005 | Start Date*: 2015-11-27 | |||||||||||
Sponsor Name:Synthetic Biologics, Inc. | |||||||||||||
Full Title: A Phase 2b Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study of SYN-004 Compared to Placebo for the Prevention of Clostridium difficile Associated Diarrhea in Patients with a Diag... | |||||||||||||
Medical condition: Prevention of Clostridium difficile infection (CDI), Clostridium difficile associated diarrhea (CDAD), antibiotic-associated diarrhea (AAD) and secondary infections with healthcare-acquired drug-re... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) PL (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004291-12 | Sponsor Protocol Number: 101.1.C.004 | Start Date*: 2008-08-18 | |||||||||||
Sponsor Name:Optimer Pharmaceuticals, Inc. | |||||||||||||
Full Title: A multi-national, multi-centre, double-blind, randomised, parallel group study to compare the safety and efficacy of 200mg PAR-101 taken q12h with 125mg Vancomycin taken q6h for ten days in subject... | |||||||||||||
Medical condition: Clostridium difficile associated diarrhoea (CDAD) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) ES (Completed) FR (Completed) SE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002876-32 | Sponsor Protocol Number: AAD-CDD-001 | Start Date*: 2008-10-06 | |||||||||||
Sponsor Name:University of Wales Swansea | |||||||||||||
Full Title: A multicentre, randomised, placebo controlled trial of lactic acid bacteria in the prevention of antibiotic-associated diarrhoea (AAD) and Clostridium difficile diarrhoea (CDD) in patients aged 65 ... | |||||||||||||
Medical condition: AAD is diarrhoea occurring in association with antibiotic treatment without an alternative cause. It occurs typically 2-8 weeks after exposure to antibiotics. The frequency of AAD varies markedly b... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004907-69 | Sponsor Protocol Number: H-030-011 | Start Date*: 2008-11-25 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Sanofi Pasteur Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: A Phase II randomized, placebo-controlled, double-blind, dose ranging study of a Clostridium difficile toxoid vaccine (ACAM-CDIFF) in subjects with Clostridium difficile-associated infection(CDI) | ||||||||||||||||||||||||||||||||||||||
Medical condition: Recurrence of Clostridium difficile Infection (CDI) | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-005244-16 | Sponsor Protocol Number: CDiffPrevTrial1 | Start Date*: 2009-06-26 | |||||||||||
Sponsor Name:Wrightington, Wigan and Leigh NHS Trust | |||||||||||||
Full Title: Probiotics for the prevention of Antibiotics associated diarrhoea and Clostridium difficile associated diarrhoea A multi-centre, double-blind, randomized placebo controlled trial | |||||||||||||
Medical condition: Prevention of Clostridium Difficile associated diarrhoea. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004924-14 | Sponsor Protocol Number: BSTEP | Start Date*: 2022-04-21 | |||||||||||||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||||||||||||
Full Title: New treatment strategy for patients with multiple recurrent Clostridioides difficile infection with bezlotoxumab as first option | |||||||||||||||||||||||
Medical condition: recurrent C. difficile infection | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002636-31 | Sponsor Protocol Number: APHP211034 | Start Date*: 2022-09-15 |
Sponsor Name:Assistance Publique Hôpitaux de Paris/DRCI | ||
Full Title: Piperacillin-tazobactam and temocillin as carbapenem-alternatives for the treatment of severe infections due to extended-spectrum beta-lactamase–producing Gram-negative Enterobacteriaceae in the in... | ||
Medical condition: severe infections due to extended-spectrum beta-lactamase–producing Gram-negative Enterobacteriaceae | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002823-27 | Sponsor Protocol Number: GAVALAGG | Start Date*: 2016-11-17 | |||||||||||
Sponsor Name:INFECTOPHARM Arzneimittel GmbH | |||||||||||||
Full Title: Placebo-kontrollierte, multizentrische, randomisierte, doppelblinde Phase III-Studie zur Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie durch add-on-Gabe v... | |||||||||||||
Medical condition: Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001081-80 | Sponsor Protocol Number: NL22172 | Start Date*: 2008-06-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort... | ||
Medical condition: To determine whether a 7-day duration of antibiotic treatment is non inferior to 14-day standard duration of treatment in adults presenting at primary care or emergency department with febrile uri... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003062-82 | Sponsor Protocol Number: RBI/FMT-CDI | Start Date*: 2016-11-01 | |||||||||||
Sponsor Name:Department of Medicine, Zealand University Hospital | |||||||||||||
Full Title: Rectal Bacteriotherapy, Faecal microbiota transplantation or oral vancomycin for the treatment of recurrent Clostridium Difficile infection: A randomised controlled trial | |||||||||||||
Medical condition: Recurrent infection with Clostridium Difficile | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003975-80 | Sponsor Protocol Number: SHORTCUT | Start Date*: 2018-03-07 |
Sponsor Name:Academic Medical Center | ||
Full Title: Shorter treatment of catheter related urinary tract infections | ||
Medical condition: Catheter related urinary tract infection (CAUTI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004591-17 | Sponsor Protocol Number: ICD-01 | Start Date*: 2021-04-23 | |||||||||||
Sponsor Name:Mikrobiomik Healthcare Company S.L. | |||||||||||||
Full Title: A randomised, controlled, open-label phase III clinical trial in patients with recurrent Clostridioides difficile (CD) infection, to evaluate the efficacy and safety of capsules of lyophilised faec... | |||||||||||||
Medical condition: Recurrent Clostridioides difficile (CD) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021621-12 | Sponsor Protocol Number: NAI114373 | Start Date*: 2010-12-01 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: NAI114373: A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of ... | |||||||||||||
Medical condition: hospitalised adults and adolescents with influenza | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) DE (Completed) FR (Completed) GB (Completed) HU (Completed) NL (Completed) CZ (Completed) NO (Completed) DK (Completed) GR (Completed) BE (Completed) PL (Completed) ES (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
